NewLimit

NewLimit

Extending human healthspan.

NewLimit is a biotechnology company working to radically extend human healthspan. They are developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells.

Work Type

Onsite

Stage

Series B

Industry

Biotech

Location

San Francisco, United States
NewLimit

Explore similar Startups to NewLimit

Startups, venture funds
& everything in between.

Explore verified companies, top VCs, and practical guides built to help you raise, invest, and grow faster.